Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
(Approval lapsed) ULTRAVIST 370 iopromide 384.5g/500mL (equivalent to 370 mg/1 mL of Iodine) solution for injection (Chile)
Section 19A approved medicine
(Approval lapsed) ULTRAVIST 370 iopromide 384.5g/500mL (equivalent to 370 mg/1 mL of Iodine) solution for injection (Chile)
Section 19A approval holder
Bayer Australia Ltd ABN 22 000 138 714
Phone
1800 008 757
Approved until
Status
Expired
Medicines in short supply/unavailable
non - ionic CONTRAST MEDIA SHORTAGE
Indication(s)
ULTRAVIST is indicated for all angiographic and urographic examinations and for contrast enhancement in computerised tomography.